Publications

Explore our published work to discover scientific research relevant to your project

Review our methodological and therapeutic expertise through a searchable database of selected scientific publications and presentations co-authored by our team members.

1,000

publications by existing team

200

scientific experts

2,500

projects undertaken

Selected authors

Diana Amari

Executive Director,
Evidence Strategy

Recent publication:
Benzodiazepine usage, healthcare resource utilization, and costs among older adults treated with common insomnia medications: a retrospective cohort study.
View Publication

Andy Surinach

Senior Director,
RWE Analytics

Recent publication:
“Real-world” outcomes and prognostic indicators among patients with high-risk muscle-invasive urothelial carcinoma.
View Publication

Darrin Benjumea

Director,
Evidence Strategy

Recent publication:
Real-world characteristics of patients with wild-type transthyretin amyloid cardiomyopathy: an analysis of electronic healthcare records in the United States.
View Publication

1000+ scientific publications

generated by our experts

A selection of scientific publications and presentations co-authored by our team members can be found below. For a wider list, please visit our online publications list.

Title	GR Author(s)	Year	Therapeutic Area	Data Source	Journal/Conference	Full Citation & Links

Title	GR Author(s)	Year	Therapeutic Area	Data Source	Journal/Conference	Full Citation & Links
Real-world characteristics of patients with wild-type transthyretin amyloid cardiomyopathy: an analysis of electronic healthcare records in the United States.	Crowley A, Benjumea D	2023	Cardiology	Optum EHR	American Journal of Cardiovascular Drugs	View
Benzodiazepine usage, healthcare resource utilization, and costs among older adults treated with common insomnia medications: a retrospective cohort study.	Amari DT	2023	Neurology	Marketscan Commercial and Medicare Supplemental	Clinicoeconomics and outcomes research	View
Treatment patterns and survival of patients with locoregional recurrence in early-stage NSCLC: a literature review of real-world evidence.	Brown AE	2022	Oncology	n/a	Medical Oncology	View
Assessment of the relevance and credibility of indirect treatment comparisons to help inform health technology assessment and reimbursement decision-making: results of a 5-country payer survey.	Katsoulis I, Graham A	2023	General Medicine	RPR Survey	ISPOR Europe	View
Paradigm Shift or Incremental Change? Real-World Evidence for Health Technology Assessment in Oncology.	Ignjatovic T	2023	Oncology	RPR Survey	ISPOR Europe	View

View our wider publication list

Looking for a scientifically rigorous partner to help you optimize your insights and evidence?

Get in touch

Clients include

“We are really impressed with the efficiency and quality of the work, your leadership skills, and the extra efforts you’ve made to ensure the results are absolutely accurate.”
HEOR/RWE client

“Genesis Research is a valued, relied upon and trusted partner on our most important deliverables.”
HEOR/RWE client

“Your culture of hiring and retaining good people provides stability and consistency.”
HEOR/RWE client

“RPR… is my go-to resource to gain real-time insights from providers and payers on the value drivers for diagnostics across disparate care areas…”
Head of Global Access, GE Healthcare

Headquarters:

HOBOKEN
111 River Street, Suite 1120
Hoboken, New Jersey 07030, US